Clostridium difficile infection in solid organ transplant recipients.
Clostridium difficile infection in solid organ transplant recipients.
复制标题
实体器官移植受者中的艰难梭菌感染。
DOI：
10.1097/mot.0b013e3283186b51
复制
发表时间：
2008
影响因子：
2.2
通讯作者：
Dubberke,ErikR
中科院分区：
文献类型：
--
作者：
Riddle,DavidJ;Dubberke,ErikR
C. difficile is a significant pathogen in solid organ transplant recipients. Multiple risk factors are found in this population that may result in more severe disease. A high index of suspicion is necessary for the early diagnosis and treatment of C. difficile infection in transplant recipients. Metronidazole and vancomycin show equivalent efficacy in the treatment for mild-to-moderate disease, but vancomycin has demonstrated superiority in the treatment of severe disease. Surgical intervention is also an important consideration in the treatment of solid organ transplant recipients with severe colitis. Rigorous infection control practices are essential for preventing the spread of C. difficile within the hospital environment.
